Vincent, John

Eplerenone in patients with systolic heart failure and mild symptoms

Zannad, F., McMurray, J. J. V., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., & Pitt, B. (2011) · New England Journal of Medicine

Heart Failure Treatment and ManagementHormonal Regulation and Hypertension

Cited by 3,111

Eplerenone and Atrial Fibrillation in Mild Systolic Heart Failure

Swedberg, K., Zannad, F., McMurray, J. J. V., Krum, H., van Veldhuisen, D. J., Shi, H., Vincent, J., & Pitt, B. (2012) · Journal of the American College of Cardiology

Atrial Fibrillation Management and OutcomesHeart Failure Treatment and Management

Cited by 313

Eplerenone in Patients With Systolic Heart Failure and Mild Symptoms: Analysis of Repeat Hospitalizations

Rogers, J. K., McMurray, J. J. V., Pocock, S. J., Zannad, F., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., & Pitt, B. (2012) · Circulation

Heart Failure Treatment and ManagementHeart rate and cardiovascular health

Cited by 224

Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)

Preiss, D., van Veldhuisen, D. J., Sattar, N., Krum, H., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., Pitt, B., Zannad, F., et al. (2012) · European Journal of Heart Failure

Heart Failure Treatment and ManagementHormonal Regulation and Hypertension

Cited by 79

Antihypertensive effect of the mineralocorticoid receptor antagonist eplerenone: a pooled analysis of patient-level data from comparative trials using regulatory-approved doses

Fernet, M., Beckerman, B., Abreu, P., Lins, K., Vincent, J., & Burgess, E. (2018) · Vascular Health and Risk Management

Blood Pressure and Hypertension StudiesHormonal Regulation and Hypertension

Cited by 7